Haemonetics: Q2 Earnings Insights


Haemonetics HAE reported its Q2 earnings results on Monday, November 7, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.


Haemonetics beat estimated earnings by 23.88%, reporting an EPS of $0.83 versus an estimate of $0.67.

Revenue was up $57.59 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 0.72% drop in the share price the next day.

Here's a look at Haemonetics's past performance:


Quarter Q1 2023 Q4 2022 Q3 2022 Q2 2022
EPS Estimate 0.51 0.60 0.73 0.61
EPS Actual 0.58 0.65 0.84 0.60
Revenue Estimate 249.00M 257.82M 266.74M 241.40M
Revenue Actual 261.46M 265.00M 259.77M 239.90M

To track all earnings releases for Haemonetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!